Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India

DNA and Cell Biology

Volumn 27, Issue 12, 2008, Pages 687-694

  Kiran, Manjula ^a   Chawla, Yogesh Kumar ^a   Kaur, Jyotdeep ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENE AMPLIFICATION; GENOTYPE; HUMAN; INDIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INDIA; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; YOUNG ADULT;

EID: 57149116137     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0805     Document Type: Article

References (31)

1. Arand, M., Mühlbauer, R., Henler, J., Jäger, E., Fuchs, J., and Winkler, L. (1996). A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione-S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 236, 184-186.
2. Baxter, S.W., Choong, D.Y., and Campbell, I.G. (2002). Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer. Cancer Lett 177, 75-81.
3. Beasley, R.P., Hwang, L.Y., and Clin, C. (1981). Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2, 1129-1133.
4. Bisceglie, A.M.D. (2002). Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Interv Radiol 13, S169-S171.
5. Chen, C.J., Yu, M.W., Liaw, Y.F., Wang, L.W., Chiamprasert, S., and Matin, F. (1996). Chronic hepatitis B carriers with null genotypes of glutathione-S-transferase M1 and T1 polymorphism who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 59, 128-134.
6. Colombo, M., Kuo, G., Choo, Q.L., Donato, M.F., DelNinno, E., and Tommasini, M.A. (1989). Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2, 1006-1008.
7. Daly, A.K., Steen, V.M., Fairbrother, K.S., and Idle, J.R. (1996). CYP2D6 multiallelism. Methods Enzymol 272, 199-210.
8. Deng, Z.L., Wei, Y.P., and Ma, Y. (2005). Polymorphism of glutathione-S-transferase mu 1 and theta 1 genes and hepatocellular carcinoma in Southern Guangxi, China. World J Gastroenterol 11, 272-274.
9. dErrico, A., Taioli, E., Chen, X., and Vinels, P. (1996). Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1, 149-173.
10. Girisha, K.M., Gilmour, A., Mastana, S., Singh, V.P., Sinha, N., and Tewari, S. (2004). T1 and M1 polymorphism in glutathione-S-transferase gene and coronary artery disease in North Indian population. Indian J Med Sci 58, 520-526.
11. Gsur, A., Zidek, T., Schnattinger, K., Feik, E., and Haidinger, G. (2003). Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer 89, 702-709.
12. Hand, P.A., Inskip, A., Gilford, J., Alldersea, J., Elexpuru Camiruaga, J., and Hayes, J.D. (1996). Allelism at the glutathione-S-transferase GSTM3 locus: interactions with GSTT1 and GSTM1 as risk factors for astrocytoma. Carcinogenesis 17, 1919-1922.
13. Hassett, C., Aicher, L., Sidhu, J.S., and Omiecinski, C.J. (1994). Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3, 421-428.
14. Jain, M., Kumar, S., Rastogi, N., Lal, P., Ghoshal, U.C., and Tiwari, A. (2006). GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India. Cancer Lett 242, 60-67.
15. Jayant, K., Rao, R.S., Nene, B.M., and Dale, P.S. (1994). Rural Cancer Registry at Barshi: Report 1988-92. Barshi: Rural Cancer Registry.
16. Kirk, G.D., Turner, P.C., Gong, Y., Lesi, O.A., Mendy, M., and Goedert, J.J. (2005). Hepatocellular carcinoma and polymorphisms in carcinogen- metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev 14, 373-379.
17. Long, X.D., Ma, Y., Wei, Y.P., and Deng, Z.L. (2006). The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res 36, 48-55.
18. Parkin, D.M., Pisani, P., and Ferlay, J. (1999). Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 80, 827-841.
19. Rebbeck, T.R. (1997). Molecular epidemiology of the human glutathione-S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6, 733-743.
20. Sarin, S.K., Thakur, V., Guptan, R.C., Saigal, S., Malhotra, V., and Thyagarajan, S.P. (2001). Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol 16, 666-673.
21. Schafer, D.F., and Sorrell, M.F. (1999). Hepatocellular carcinoma. Lancet 353, 1253-1257.
22. Shou, M., Gonzalez, F.J., and Gelboin, H.V. (1996). Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2 and epoxide hydrolase. Biochemistry 35, 15807-15813.
23. Sonzogni, L., Silvestri, L., de Silvestri, A., Gritti, C., Foti, L., and Zavaglia, C. (2002). Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease. Hepatology 36, 195-201.
24. Sreeja, L., Syamala, V., Hariharan, S., Madhavan, J., Devan, S.C., and Ankathil, R. (2005). Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50, 618-627.
25. Srivastava, D., Mandhani, A., Mittal, B., and Mittal, R.D. (2005). Genetic polymorphism of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int 95, 170-173.
26. Sun, C.A., Wang, L.Y., Chen, C.J., Lu, S.N., You, S.L., and Wang, L.W. (2001). Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis 22, 1289-1294.
27. Szmuness, W. (1978). Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 24, 40-69.
28. Tiemersma, E.W., Omer, R.E., Bunschoten, A., Veer, P., Kok, F.J., and Idris, M.O. (2001). Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 10, 785-791.
29. Wong, N.A.C.S., Rae, F., Bathgate, A., Smith, C.A.D., and Harrison, D.J. (2000). Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population. Toxicol Lett 115, 17-22.
30. Yoshikawa, M., Hiyama, K., Ishioka, S., Maeda, H., Maeda, A., and Yamakido, M. (2000). Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int J Mol Med 5, 49-53.
31. Zhou, L., Liu, J., and Luo, F. (2006). Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 12, 1175-1181.